NEVRO CORP Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEVRO CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEVRO CORP for March 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 1.44 | 25,500 | 36,720 | 37,404 | |
| Mar 21 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 1.44 | 25,500 | 36,720 | 30,000 | 4.5 K to 30 K (+566.67 %) |
| Mar 16 2016 | NVRO | NEVRO CORP | Schmitz Patrick | Vice President, Ope ... | Option Exercise | A | 57.89 | 20,000 | 1,157,800 | 20,000 | |
| Mar 16 2016 | NVRO | NEVRO CORP | Schmitz Patrick | Vice President, Ope ... | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
| Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | A | 54.50 | 67,432 | 3,675,044 | 67,432 | |
| Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | A | 54.50 | 202,294 | 11,025,023 | 202,294 | |
| Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | M | 3.60 | 485 | 1,746 | 130,390 | |
| Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Grant | A | 0.00 | 15,924 | 0 | 64,180 | 48.3 K to 64.2 K (+33.00 %) |
| Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Grant | A | 0.00 | 47,771 | 0 | 48,256 | 485 to 48.3 K (+9,849.69 %) |
| Mar 11 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Buy | M | 3.60 | 485 | 1,746 | 485 | 0 to 485 |
| Mar 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | M | 3.60 | 37,000 | 133,200 | 100,875 | |
| Mar 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Buy | M | 3.60 | 37,000 | 133,200 | 37,413 | 413 to 37.4 K (+8,958.84 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 58.99 | 50 | 2,950 | 30,921 | 31 K to 30.9 K (-0.16 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 57.75 | 407 | 23,503 | 30,971 | 31.4 K to 31 K (-1.30 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 56.22 | 150 | 8,433 | 31,378 | 31.5 K to 31.4 K (-0.48 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 55.01 | 6,059 | 333,296 | 31,528 | 37.6 K to 31.5 K (-16.12 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 58.99 | 50 | 2,950 | 99,220 | 99.3 K to 99.2 K (-0.05 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 57.75 | 408 | 23,560 | 99,270 | 99.7 K to 99.3 K (-0.41 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 56.22 | 150 | 8,433 | 99,678 | 99.8 K to 99.7 K (-0.15 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 55.01 | 6,058 | 333,241 | 99,828 | 105.9 K to 99.8 K (-5.72 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 59.06 | 200 | 11,813 | 552,587 | 552.8 K to 552.6 K (-0.04 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 57.80 | 1,465 | 84,675 | 552,787 | 554.3 K to 552.8 K (-0.26 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 56.80 | 8,688 | 493,495 | 554,252 | 562.9 K to 554.3 K (-1.54 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 55.10 | 16,314 | 898,839 | 562,940 | 579.3 K to 562.9 K (-2.82 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 1.44 | 10,000 | 14,400 | 62,904 | |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 1.44 | 4,500 | 6,480 | 72,904 | |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 59.06 | 100 | 5,906 | 4,500 | 4.6 K to 4.5 K (-2.17 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 57.68 | 600 | 34,608 | 4,600 | 5.2 K to 4.6 K (-11.54 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 56.74 | 3,314 | 188,023 | 5,200 | 8.5 K to 5.2 K (-38.92 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 56.07 | 3,100 | 173,803 | 8,514 | 11.6 K to 8.5 K (-26.69 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 54.81 | 1,384 | 75,858 | 11,614 | 13 K to 11.6 K (-10.65 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 53.90 | 1,202 | 64,785 | 12,998 | 14.2 K to 13 K (-8.46 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 52.30 | 300 | 15,689 | 14,200 | 14.5 K to 14.2 K (-2.07 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 1.44 | 10,000 | 14,400 | 14,500 | 4.5 K to 14.5 K (+222.22 %) |
| Mar 03 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 1.44 | 4,500 | 6,480 | 4,500 | 0 to 4.5 K |